Rigel Pharma (RIGL) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $38.72 +1.12%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
CRMT, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $29.53 million versus the consensus estimate of $31.48 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
- Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
